Market capitalization | $221.02m |
Enterprise Value | $237.25m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 34.99 |
EV/Sales (TTM) EV/Sales | 2.51 |
P/S ratio (TTM) P/S ratio | 2.34 |
P/B ratio (TTM) P/B ratio | 1.90 |
Revenue growth (TTM) Revenue growth | 20.66% |
Revenue (TTM) Revenue | $94.37m |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
7 Analysts have issued a OptimizeRx Corporation forecast:
7 Analysts have issued a OptimizeRx Corporation forecast:
Mar '25 |
+/-
%
|
||
Revenue | 94 94 |
21%
21%
|
|
Gross Profit | 56 56 |
26%
26%
|
|
EBITDA | 1.06 1.06 |
113%
113%
|
EBIT (Operating Income) EBIT | -3.30 -3.30 |
70%
70%
|
Net Profit | -15 -15 |
15%
15%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.
Head office | United States |
CEO | Stephen Silvestro |
Employees | 129 |
Founded | 1985 |
Website | www.optimizerx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.